Cardiotoxicity Innovations
Cardio-toxicity can be called cardiac muscle dysfunction due to poisonous or deleterious effects on the heart of certain compounds. The key causes for cardiac toxicity are consumption of such pharmaceutical
drugs such as bupivacaine or chemotherapy. Cardiotoxic agent has an effect on heart electrophysiological activity. This toxicity directly affects
cancer chemotherapy patients, Antineoplastic
drugs are among the main cardio-toxic
drugs that cause vascular system toxicity. Innovations are new technologies, systems or procedures. Innovations are applying better solutions that satisfy new needs, inarticulate needs or existing market needs. It is proficient by making products more efficient, Processes, facilities, innovations, or innovative concepts the market, government , and society are readily accessible. Innovations are an original and innovative item that comes into the market or culture as a important, modern one.
High Impact List of Articles
-
Current controversies in emergency room CT: could trauma total-body CT scanning improve clinical outcome?
Ludo F Beenen
Perspective: Clinical Practice
-
Current controversies in emergency room CT: could trauma total-body CT scanning improve clinical outcome?
Ludo F Beenen
Perspective: Clinical Practice
-
Targeting angiogenesis in non-small-cell lung cancer: a focus on current approaches and future developments
Belisario A Arango, Luis E Aguirre, Cesar A Perez, Michel Velez, Edgardo S Santos,Luis E Raez
Review Article: Clinical Practice
-
Targeting angiogenesis in non-small-cell lung cancer: a focus on current approaches and future developments
Belisario A Arango, Luis E Aguirre, Cesar A Perez, Michel Velez, Edgardo S Santos,Luis E Raez
Review Article: Clinical Practice
-
Cardiovascular disease and venous thromboembolism in inflammatory bowel disease
Mia Hindi and Amar R Deshpande
Review Article: Clinical Practice
-
Cardiovascular disease and venous thromboembolism in inflammatory bowel disease
Mia Hindi and Amar R Deshpande
Review Article: Clinical Practice
-
Sorafenib: a multitargeted oral agent for the treatment of advanced renal cell cancer
Michelle Lockley and Tim Eisen
Drug Evaluation: Clinical Practice
-
Sorafenib: a multitargeted oral agent for the treatment of advanced renal cell cancer
Michelle Lockley and Tim Eisen
Drug Evaluation: Clinical Practice
-
Glossary: Volume 4 Issue 3
Appendices: Clinical Practice
-
Glossary: Volume 4 Issue 3
Appendices: Clinical Practice
-
Increased expression of CD40 ligand and C-reactive protein in patients with restenosis after percutaneous coronary intervention
Jin-Chuan Yan, Yi Liang, Gen-Shan Ma, Jian Zhu, Yi Feng, Dan Luo, Zong-Gui Wu, Xian-Tao Kong, Ren-Qian Zong and Lin-Zen Zhan
Research Article: Clinical Practice
-
Increased expression of CD40 ligand and C-reactive protein in patients with restenosis after percutaneous coronary intervention
Jin-Chuan Yan, Yi Liang, Gen-Shan Ma, Jian Zhu, Yi Feng, Dan Luo, Zong-Gui Wu, Xian-Tao Kong, Ren-Qian Zong and Lin-Zen Zhan
Research Article: Clinical Practice
Relevant Topics in Clinical